Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 9, 2023
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
[ Thu, Mar 09th 2023
] - WOPRAI
Andrew Fein Reiterated (TCRX) at Strong Buy and Held Target at $15 on, Mar 9th, 2023
Andrew Fein of HC Wainwright & Co., Reiterated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $15 on, Mar 9th, 2023.
Andrew, nor any peers, have made any analyst calls on TCRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30